1. Home
  2. RELI vs ARTL Comparison

RELI vs ARTL Comparison

Compare RELI & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RELI
  • ARTL
  • Stock Information
  • Founded
  • RELI 2013
  • ARTL 2011
  • Country
  • RELI United States
  • ARTL United States
  • Employees
  • RELI N/A
  • ARTL N/A
  • Industry
  • RELI Specialty Insurers
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • RELI Finance
  • ARTL Health Care
  • Exchange
  • RELI Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • RELI 3.5M
  • ARTL 3.1M
  • IPO Year
  • RELI N/A
  • ARTL N/A
  • Fundamental
  • Price
  • RELI $1.88
  • ARTL $21.12
  • Analyst Decision
  • RELI
  • ARTL Buy
  • Analyst Count
  • RELI 0
  • ARTL 2
  • Target Price
  • RELI N/A
  • ARTL $30.00
  • AVG Volume (30 Days)
  • RELI 3.6M
  • ARTL 1.3M
  • Earning Date
  • RELI 07-24-2025
  • ARTL 08-12-2025
  • Dividend Yield
  • RELI N/A
  • ARTL N/A
  • EPS Growth
  • RELI N/A
  • ARTL N/A
  • EPS
  • RELI N/A
  • ARTL N/A
  • Revenue
  • RELI $14,208,143.00
  • ARTL N/A
  • Revenue This Year
  • RELI N/A
  • ARTL N/A
  • Revenue Next Year
  • RELI N/A
  • ARTL N/A
  • P/E Ratio
  • RELI N/A
  • ARTL N/A
  • Revenue Growth
  • RELI 2.40
  • ARTL N/A
  • 52 Week Low
  • RELI $0.97
  • ARTL $4.92
  • 52 Week High
  • RELI $5.11
  • ARTL $25.58
  • Technical
  • Relative Strength Index (RSI)
  • RELI 61.88
  • ARTL 59.07
  • Support Level
  • RELI $1.88
  • ARTL $5.76
  • Resistance Level
  • RELI $2.60
  • ARTL $6.15
  • Average True Range (ATR)
  • RELI 0.36
  • ARTL 0.46
  • MACD
  • RELI 0.08
  • ARTL -0.04
  • Stochastic Oscillator
  • RELI 52.85
  • ARTL 69.53

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: